Cargando…
ALDH1 Bio-activates Nifuroxazide to Eradicate ALDH(High) Melanoma-Initiating Cells
5-Nitrofurans are antibiotic pro-drugs that have potential as cancer therapeutics. Here, we show that 5-nitrofurans can be bio-activated by aldehyde dehydrogenase (ALDH) 1A1/1A3 enzymes that are highly expressed in a subpopulation of cancer-initiating (stem) cells. We discover that the 5-nitrofuran,...
Autores principales: | Sarvi, Sana, Crispin, Richard, Lu, Yuting, Zeng, Lifan, Hurley, Thomas D., Houston, Douglas R., von Kriegsheim, Alex, Chen, Che-Hong, Mochly-Rosen, Daria, Ranzani, Marco, Mathers, Marie E., Xu, Xiaowei, Xu, Wei, Adams, David J., Carragher, Neil O., Fujita, Mayumi, Schuchter, Lynn, Unciti-Broceta, Asier, Brunton, Valerie G., Patton, E. Elizabeth |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cell Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6309505/ https://www.ncbi.nlm.nih.gov/pubmed/30293938 http://dx.doi.org/10.1016/j.chembiol.2018.09.005 |
Ejemplares similares
-
ALDH2 variance in disease and populations
por: Chen, Che-Hong, et al.
Publicado: (2022) -
Palladium-Mediated Dealkylation of N-Propargyl-Floxuridine as a Bioorthogonal Oxygen-Independent Prodrug Strategy
por: Weiss, Jason T., et al.
Publicado: (2015) -
N-alkynyl derivatives of 5-fluorouracil: susceptibility to palladium-mediated dealkylation and toxigenicity in cancer cell culture
por: Weiss, Jason T., et al.
Publicado: (2014) -
Development of
Potent Inhibitors of Receptor Tyrosine
Kinases by Ligand-Based Drug Design and Target-Biased Phenotypic Screening
por: Myers, Samuel H., et al.
Publicado: (2018) -
Impact of common ALDH2 inactivating mutation and alcohol consumption on Alzheimer’s disease
por: Seike, Takuya, et al.
Publicado: (2023)